Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation

Ulf W Tunn,1 Damian Gruca,2 Peter Bacher3 1Urological Department, Prostate Center, Offenbach, Germany; 2AbbVie Deutschland GmbH and Co, KG, Ludwigshafen, Germany; 3AbbVie, North Chicago, IL, USA Abstract: For nearly three decades, gonadotropin-releasing hormone (GnRH) agonists, particularly leupror...

Full description

Saved in:
Bibliographic Details
Main Authors: Tunn UW, Gruca D, Bacher P
Format: article
Language:EN
Published: Dove Medical Press 2013
Subjects:
Online Access:https://doaj.org/article/ba306e3cef4144209d7f8a881f32d087
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items